Clovis Oncology, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Clovis Oncology, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2022.
  • Clovis Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 145M shares, a 13.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 145M +16.8M +13.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 144M +26.1M +22% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 144M +39.3M +37.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 129M +25.4M +24.5% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 128M +39.7M +44.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 118M +30.2M +34.3% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 105M +31.1M +42.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 104M +48.7M +88.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 88.3M +33.5M +61.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 88.2M +35M +65.9% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 73.5M +20.5M +38.7% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 55M +2.16M +4.09% Dec 31, 2019 10-K 2021-02-25
Q3 2019 54.8M +2.1M +3.98% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 53.2M +533K +1.01% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 53M +2.3M +4.53% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 52.8M +2.23M +4.42% Dec 31, 2018 10-K 2020-02-26
Q3 2018 52.7M +3.71M +7.56% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 52.6M +3.79M +7.77% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 50.7M +5.93M +13.2% Mar 31, 2018 10-Q 2019-05-07
Q4 2017 50.6M +11.8M +30.6% Dec 31, 2017 10-Q 2019-05-07
Q3 2017 49M +10.4M +27% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 48.8M +10.3M +26.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 44.8M +6.41M +16.7% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 38.7M +365K +0.95% Dec 31, 2016 10-K 2018-02-27
Q3 2016 38.6M +302K +0.79% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 38.5M +4.35M +12.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 38.4M +4.3M +12.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 38.4M +4.38M +12.9% Dec 31, 2015 10-K 2017-02-23
Q3 2015 38.3M +4.32M +12.7% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 34.1M +183K +0.54% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 34.1M +161K +0.48% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 34M +79.9K +0.24% Dec 31, 2014 10-K 2016-02-29
Q3 2014 34M +3.79M +12.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 34M +3.79M +12.6% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 33.9M +7.68M +29.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 33.9M +7.69M +29.3% Dec 31, 2013 10-K 2015-02-27
Q3 2013 30.2M +4.03M +15.4% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 30.2M +4.03M +15.4% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 26.2M +3.84M +17.2% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 26.2M +3.83M +17.1% Dec 31, 2012 10-K 2014-02-28
Q3 2012 26.1M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 26.1M Jun 30, 2012 10-Q 2012-08-10
Q1 2012 22.4M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 22.4M Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.